StreetInsider.com News Articles

DENTSPLY SIRONA (XRAY) PT Raised to $13 at BMO Capital

Fri, 07 Aug 2026 08:11:25 -0400

BMO Capital analyst Vik Chopra raised the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $13.00 (from $12.00) while maintaining a Market Perform rating.

Form 8-K/A DENTSPLY SIRONA Inc. For: Aug 06

Fri, 07 Aug 2026 07:42:00 -0400

si-local-file:///var/storage/secattach/20260807/26887600.html

Form 8-K/A DENTSPLY SIRONA Inc. For: Aug 06

Fri, 07 Aug 2026 07:42:00 -0400

si-local-file:///var/storage/secattach/20260807/26887600.html

Dentsply Sirona (XRAY) Tops Q2 EPS by 17c ; Offers Guidance

Fri, 07 Aug 2026 02:18:17 -0400

Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.52, $0.17 better than the analyst estimate of $0.35. Revenue for the quarter came in at $898 million versus the consensus estimate of $889.15 million.

FY 2026 Outlook:-

Net sales in the range of $3.5 billion to $3.6 billion vs consensus $3.58 billion.
EPS in the range of $1.40 to $1.50 vs consensus $1.42.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

Form 10-Q DENTSPLY SIRONA Inc. For: Jun 30

Thu, 06 Aug 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260806/26885237.html

Form 10-Q DENTSPLY SIRONA Inc. For: Jun 30

Thu, 06 Aug 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260806/26885237.html

Form SCHEDULE 13G/A DENTSPLY SIRONA Inc. Filed by: First Eagle Investment Management, LLC

Thu, 06 Aug 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260806/26884358.html

Form SCHEDULE 13G/A DENTSPLY SIRONA Inc. Filed by: First Eagle Investment Management, LLC

Thu, 06 Aug 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260806/26884358.html

Form 8-K DENTSPLY SIRONA Inc. For: Aug 06

Thu, 06 Aug 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260806/26884193.html

Form 8-K DENTSPLY SIRONA Inc. For: Aug 06

Thu, 06 Aug 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260806/26884193.html

Dentsply Sirona Reports Second Quarter 2026 Results

Thu, 06 Aug 2026 16:01:00 -0400

News Summary

Reported net sales of $898 million
Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18
Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52
Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across Canada
Repurchased 1.3 million shares of common stock during the quarter
Reiterates 2026 outlook for net sales and adjusted EPS

CHARLOTTE, N.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2026.

Dentsply Sirona Reports Second Quarter 2026 Results

Thu, 06 Aug 2026 16:01:00 -0400

News Summary

Reported net sales of $898 million
Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18
Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52
Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across Canada
Repurchased 1.3 million shares of common stock during the quarter
Reiterates 2026 outlook for net sales and adjusted EPS

CHARLOTTE, N.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2026.

DENTSPLY SIRONA (XRAY) PT Raised to $14 at Piper Sandler

Wed, 29 Jul 2026 06:57:46 -0400

Piper Sandler analyst Jason Bednar raised the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $14.00 (from $13.00) while maintaining a Neutral rating.

Form 3 DENTSPLY SIRONA Inc. For: Jul 20 Filed by: Fortson John C.

Tue, 21 Jul 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260721/26795872.html

Form 3 DENTSPLY SIRONA Inc. For: Jul 20 Filed by: Fortson John C.

Tue, 21 Jul 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260721/26795872.html

Dentsply Sirona to Host Second Quarter Conference Call on August 6th

Tue, 21 Jul 2026 16:15:00 -0400

CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call.

Conference Call / Webcast Information

The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For

Dentsply Sirona to Host Second Quarter Conference Call on August 6th

Tue, 21 Jul 2026 16:15:00 -0400

Conference Call / Webcast Information

The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For

BMO Capital Starts DENTSPLY SIRONA (XRAY) at Market Perform

Wed, 08 Jul 2026 16:24:03 -0400

BMO Capital initiates coverage on DENTSPLY SIRONA (NASDAQ: XRAY) with a Market Perform rating and a price target of $12.00.

For an analyst ratings summary and ratings history on DENTSPLY SIRONA click here. For more ratings news on DENTSPLY SIRONA click here.

Shares of DENTSPLY SIRONA closed at $12.19 yesterday.

Form SCHEDULE 13G/A DENTSPLY SIRONA Inc. Filed by: BlackRock, Inc.

Wed, 08 Jul 2026 11:13:00 -0400

si-local-file:///var/storage/secattach/20260708/26746089.html

Form SCHEDULE 13G/A DENTSPLY SIRONA Inc. Filed by: BlackRock, Inc.

Wed, 08 Jul 2026 11:13:00 -0400

si-local-file:///var/storage/secattach/20260708/26746089.html

Piper Sandler: 'DENTSPLY SIRONA (XRAY) most at risk; Own Manufacturers at Your Own Risk'

Tue, 07 Jul 2026 07:58:44 -0400

Piper Sandler analyst Jason Bednar reiterated a Neutral rating and $13.00 price target on DENTSPLY SIRONA (NASDAQ: XRAY).

The analyst commented: "XRAY most at risk; Own Manufacturers at Your Own Risk, Buy HSIC on Any Pull Back; The threat of MDLN expanding its dental presence isn't new as this has been a question in our investor conversations ever since Sinclair was acquired, but we do believe it's likely the whole group underperforms if MDLN makes a more aggressive move in the U.S. dental market. It's our view those concerns are more founded for the branded general consumables manufacturers (XRAY more than

Form 4 DENTSPLY SIRONA Inc. For: Jun 30 Filed by: MAZELSKY JONATHAN JAY

Wed, 01 Jul 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260701/26721419.html

Form 4 DENTSPLY SIRONA Inc. For: Jun 30 Filed by: MAZELSKY JONATHAN JAY

Wed, 01 Jul 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260701/26721419.html

Form S-8 DENTSPLY SIRONA Inc.

Fri, 26 Jun 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260626/26695397.html

Form S-8 DENTSPLY SIRONA Inc.

Fri, 26 Jun 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260626/26695397.html